U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Structurally Diverse
Created
by admin
on Sat Dec 16 11:43:54 GMT 2023
Edited
by admin
on Sat Dec 16 11:43:54 GMT 2023
Source Materials Class ORGANISM
Source Materials Type VIRUS
Organism Family Retroviridae
Organism Genus Lentivirus
Organism Species human immunodeficiency virus 1
Author NONE
Part WHOLE
Record UNII
859A956UY8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
Common Name English
HIV-1
Common Name English
Code System Code Type Description
FDA UNII
859A956UY8
Created by admin on Sat Dec 16 11:44:01 GMT 2023 , Edited by admin on Sat Dec 16 11:44:01 GMT 2023
PRIMARY
Related Record Type Details
Structure of NELFINAVIR
INHIBITOR->TARGET ORGANISM
Other
TIFUVIRTIDE
INHIBITOR->TARGET ORGANISM
Structure of RILPIVIRINE
INHIBITOR->TARGET ORGANISM
Structure of DIDANOSINE
INHIBITOR->TARGET ORGANISM
Structure of Thalassiolin C
INHIBITOR->TARGET ORGANISM
Structure of LOVIRIDE
INHIBITOR->TARGET ORGANISM
Structure of Fipravirimat
INHIBITOR->TARGET ORGANISM
HIV maturation inhibitor: Exhibited robust antiviral activity against a panel of HIV-1 clinical isolates, with a mean EC50 of 9 nM
EC50
Teropavimab
INHIBITOR->TARGET ORGANISM
Structure of BMS-955176
INHIBITOR->TARGET ORGANISM
The observation of gastrointestinal intolerability and the emergence of resistant virus led to the cessation of development activities in favor of compounds with improved antiviral profiles.
EC50
Structure of BICTEGRAVIR
INHIBITOR->TARGET ORGANISM
Structure of FOSTEMSAVIR
INHIBITOR->TARGET ORGANISM
Structure of RM-5038
INHIBITOR->TARGET ORGANISM
Upregulates innate immunity
Structure of AMD-8664
INHIBITOR->TARGET ORGANISM
Structure of ROMIDEPSIN
INHIBITOR->TARGET ORGANISM
Structure of STAVUDINE
INHIBITOR->TARGET ORGANISM
Structure of Thalassiolin B
INHIBITOR->TARGET ORGANISM
Structure of IXAZOMIB CITRATE
INHIBITOR->TARGET ORGANISM
Structure of TEMSAVIR
INHIBITOR->TARGET ORGANISM
Structure of TMC-310911
INHIBITOR->TARGET ORGANISM
Structure of 2-FLUORODIDEOXYCYTIDINE
INHIBITOR->TARGET ORGANISM
IN-VITRO
Structure of DAPIVIRINE
INHIBITOR->TARGET ORGANISM
Structure of THIAZOLOBENZIMIDAZOLE
INHIBITOR->TARGET ORGANISM
Structure of DS-003
INHIBITOR->TARGET ORGANISM
Structure of OBEFAZIMOD
INHIBITOR->TARGET ORGANISM
Structure of CENICRIVIROC
INHIBITOR->TARGET ORGANISM
Structure of DEXELVUCITABINE
INHIBITOR->TARGET ORGANISM
Structure of VERDINEXOR
INHIBITOR->TARGET ORGANISM
Structure of CL-197
INHIBITOR->TARGET ORGANISM
infected with HIV-luc/VSV-G (1 ng p24Gag).
EC50
VRC-01 (PRODUCED IN TOBACCO)
INHIBITOR->TARGET ORGANISM
Structure of NEVIRAPINE
INHIBITOR->TARGET ORGANISM
IC50 values (50% inhibitory concentration) ranged from 10-100 nM against laboratory and clinical isolates of HIV-1.
IC50
Structure of DARUNAVIR
INHIBITOR->TARGET ORGANISM
SEMZUVOLIMAB
INHIBITOR->TARGET ORGANISM
An Fc-aglycosylated, non–T-cell–depleting and CD4-specific humanized IgG1 derived from the parent murine B4, which binds to discontinuous, conformational epitopes on the HIV-receptor complex, including CD4 domain 1, and competitively blocks HIV entry
VRC07-523LS
INHIBITOR->TARGET ORGANISM
Structure of ELUNONAVIR
INHIBITOR->TARGET ORGANISM
Structure of LABUVIRTIDE
INHIBITOR->TARGET ORGANISM
VRC-01LS
INHIBITOR->TARGET ORGANISM
Structure of MK-2048
INHIBITOR->TARGET ORGANISM
EC50
Structure of Maraviroc
INHIBITOR->TARGET ORGANISM
Structure of Pirmitegravir
INHIBITOR->TARGET ORGANISM
Structure of TIPRANAVIR
INHIBITOR->TARGET ORGANISM
Tipranavir (TPV) is a non-peptidic HIV-1 protease inhibitor that inhibits the virus-specific processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions.
Structure of STAMPIDINE
INHIBITOR->TARGET ORGANISM
Structure of ABACAVIR
INHIBITOR->TARGET ORGANISM
Structure of BRECANAVIR
INHIBITOR->TARGET ORGANISM
Structure of APLAVIROC
INHIBITOR->TARGET ORGANISM
HIVIG
INHIBITOR->TARGET ORGANISM
Zinlirvimab
INHIBITOR->TARGET ORGANISM
Structure of TNK-651
INHIBITOR->TARGET ORGANISM
Structure of MOZENAVIR
INHIBITOR->TARGET ORGANISM
Structure of ANCRIVIROC
INHIBITOR->TARGET ORGANISM
Structure of ELVUCITABINE
INHIBITOR->TARGET ORGANISM
Structure of GW-678248
INHIBITOR->TARGET ORGANISM
Preclinical assessment of GW678248 indicates that this compound potently inhibits wild-type (WT) and mutant human immunodeficiency virus type 1 (HIV-1) reverse transcriptase in biochemical assays, with 50% inhibitory concentrations (IC50s) between 0.8 and 6.8 nM. In HeLa CD4 MAGI cell culture virus replication assays, GW678248 has an IC50 of 21 nM against HIV-1 isogenic strains with single or double mutations known to be associated with NNRTI resistance, including L100I, K101E, K103N, V106A/I/M, V108I, E138K, Y181C, Y188C, Y188L, G190A/E, P225H, and P236L and various combinations. An IC50 of 86 nM was obtained with a mutant virus having V106I, E138K, and P236L mutations that resulted from serial passage of WT virus in the presence of GW678248.
Structure of RALTEGRAVIR
INHIBITOR->TARGET ORGANISM
Structure of TENOFOVIR DIPHOSPHATE
INHIBITOR->TARGET ORGANISM
Structure of TIVIRAPINE
INHIBITOR->TARGET ORGANISM
Structure of GW-695634
INHIBITOR->TARGET ORGANISM
Structure of AMPRENAVIR
INHIBITOR->TARGET ORGANISM
Structure of RITONAVIR
INHIBITOR->TARGET ORGANISM
Structure of CAPRAVIRINE
INHIBITOR->TARGET ORGANISM
Structure of CTP-518
INHIBITOR->TARGET ORGANISM
Structure of GS-9148
INHIBITOR->TARGET ORGANISM
Structure of BI-224436
INHIBITOR->TARGET ORGANISM
Structure of Thalassiolin A
INHIBITOR->TARGET ORGANISM
Structure of DOLUTEGRAVIR
INHIBITOR->TARGET ORGANISM
Structure of PPL-100
INHIBITOR->TARGET ORGANISM
Structure of EMTRICITABINE 5'-TRIPHOSPHATE
INHIBITOR->TARGET ORGANISM
HILTONOL
INHIBITOR->TARGET ORGANISM
Structure of CENSAVUDINE
INHIBITOR->TARGET ORGANISM
Structure of FOSDEVIRINE
INHIBITOR->TARGET ORGANISM
Structure of CABOTEGRAVIR
INHIBITOR->TARGET ORGANISM
Structure of BEVIRIMAT
INHIBITOR->TARGET ORGANISM
Structure of EMTRICITABINE
INHIBITOR->TARGET ORGANISM
Structure of LAMIVUDINE
INHIBITOR->TARGET ORGANISM
Structure of Ulonivirine
INHIBITOR->TARGET ORGANISM
Structure of VICRIVIROC
INHIBITOR->TARGET ORGANISM
Structure of SAQUINAVIR
INHIBITOR->TARGET ORGANISM
IC50
VRC-01
INHIBITOR->TARGET ORGANISM
Structure of DORAVIRINE
INHIBITOR->TARGET ORGANISM
Structure of RM-4848
INHIBITOR->TARGET ORGANISM
Upregulates innate immunity
Structure of PALINAVIR
INHIBITOR->TARGET ORGANISM
Structure of LOPINAVIR
INHIBITOR->TARGET ORGANISM
Structure of AMDOXOVIR
INHIBITOR->TARGET ORGANISM
Structure of FAROPENEM SODIUM
INHIBITOR->TARGET ORGANISM
PGT-121
INHIBITOR->TARGET ORGANISM
Structure of PF-04776548
INHIBITOR->TARGET ORGANISM
ALVIRCEPT SUDOTOX
INHIBITOR->TARGET ORGANISM
Structure of EFAVIRENZ
INHIBITOR->TARGET ORGANISM
OB-002
INHIBITOR->TARGET ORGANISM
DOES NOT ACTIVATE CCR5
IC50
Structure of VORINOSTAT
INHIBITOR->TARGET ORGANISM
LEFITOLIMOD
INHIBITOR->TARGET ORGANISM
Structure of LOBUCAVIR
INHIBITOR->TARGET ORGANISM
Structure of TROVIRDINE
INHIBITOR->TARGET ORGANISM
GRIFFITHSIN
INHIBITOR->TARGET ORGANISM
INHIBITS BINDING
ENFUVIRTIDE
INHIBITOR->TARGET ORGANISM
Structure of LASINAVIR
INHIBITOR->TARGET ORGANISM
Structure of LERSIVIRINE
INHIBITOR->TARGET ORGANISM
Structure of DROXINAVIR
INHIBITOR->TARGET ORGANISM
Structure of ATEVIRDINE
INHIBITOR->TARGET ORGANISM
Structure of TENOFOVIR ANHYDROUS
INHIBITOR->TARGET ORGANISM
EC50
Structure of TELINAVIR
INHIBITOR->TARGET ORGANISM
Structure of IQP-0528
INHIBITOR->TARGET ORGANISM
EC50
Structure of CLAFICAPAVIR
INHIBITOR->TARGET ORGANISM
Structure of ATAZANAVIR
INHIBITOR->TARGET ORGANISM
EC50
Structure of ISLATRAVIR ANHYDROUS
INHIBITOR->TARGET ORGANISM
Structure of DW-D-5
INHIBITOR->TARGET ORGANISM
Inhibits cytopathic effect
EC50
Structure of TALVIRALINE
INHIBITOR->TARGET ORGANISM
Structure of BILR-355
INHIBITOR->TARGET ORGANISM
The in vitro results showed that the EC50 of BILR 355 was 0.26 ng/ml (0.59 nM) against wild-type HIV-1 and ranged from 1.5 to 13 ng/ml (3.4 –29 nM) against clinically common single and double NNRTI mutations .
Structure of APRICITABINE
INHIBITOR->TARGET ORGANISM
Structure of DMP-323
INHIBITOR->TARGET ORGANISM
Structure of ZIDOVUDINE
INHIBITOR->TARGET ORGANISM
Structure of Depulfavirine
INHIBITOR->TARGET ORGANISM
Structure of OPAVIRALINE
INHIBITOR->TARGET ORGANISM
Structure of MAVORIXAFOR
INHIBITOR->TARGET ORGANISM
Structure of LENACAPAVIR
INHIBITOR->TARGET ORGANISM
GPI-2A
INHIBITOR->TARGET ORGANISM
Structure of EMIVIRINE
INHIBITOR->TARGET ORGANISM
Structure of NAVURIDINE
INHIBITOR->TARGET ORGANISM
Structure of Bavtavirine
INHIBITOR->TARGET ORGANISM
Structure of IDX-989
INHIBITOR->TARGET ORGANISM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966